Leading Out of Silos: The Suite Spot

The Suite Spot is a fireside chat about all topics IT and OT. We will attempt to bring clarity to the business value of traditionally tech topics. We remove the fog of acronym war and deliver to you the value you need to make these complex technologies work for your business.

Powered by RedCircle

Carlos Vargas, host of The Suite Spot, was joined with co-hosts Howard Holton and Paul Lewis in a discussion on the possibilities of AI. Is the world ready for AI to capture and become the human experience? Not yet, and neither is the technology. It’s the romanticized, big-screen perspective of AI that many visualize. But AI is instrumental in so many aspects of human life, just not to that degree.

Paul said, “The conversation of synthetic humans is far away. It’s because data science can’t be applied to people. They are messy. They are individuals. People are unpredictable and have free will. At this point, data science will stick to objects that are engineered to provide data.”

Is AI’s impact on human behavior viable? It would require lots of data and computing power. But what about what AI can do now as it interacts with humans?

Howard argued, “Yes, you’re correct that AI can’t know 100% of the time how a human is going to react. But that’s not really the goal of AI. Right now, with the right data and algorithms, you can target an audience to capture about 80%. AI has first to understand people before it can recreate them.”

The discussion of AI and its impact on humans might be around the replaceability of humans in a scenario like driverless cars.

Howard said, “Automated cars will be better drivers than people in 5 years, but humans won’t be comfortable with automated cars for 15 years. The car has to be autonomous by itself. It can feed data back on how to make the care better at its job. The decision-making process should be self-contained. The human problem is that we think we’re better decision-makers, but we’re not.”

If AI can replace drivers, what other roles are possible. Could AI be a better lawyer? Howard commented, “Most lawyers never appear in court. A computer is good at many things attorneys do, but it can’t argue in front of a jury. An empathetic reaction isn’t possible. AI on a computer could listen to what happens in court and recommend arguments.”

Paul added, “This is more augmented and assisted AI, which is what we’re seeing now.

Make Sure to Subscribe to The Suite Spot to Stay Up to Date!

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More